Pinealon
Neurological
A tripeptide (Glu-Asp-Arg) bioregulator that targets the pineal gland and central nervous system. Developed by the St. Petersburg Institute of Bioregulation and Gerontology, it is studied for neuroprotective effects, circadian rhythm regulation, melatonin normalization, and cognitive support in aging.
NeuroprotectionNerve RegenerationLongevityNeurologicalOralSubcutaneous (SubQ)Sleep ImprovementCognitive EnhancementAnti-Aging
Community
1
Tracking
12
Doses Logged
10mg/day
Common Dose
—
Adverse Rate
All dosages:10mg/day20mg/day10mg 2x/day
Reported Adverse Effects
No adverse effects reported yet
Community Consensus
No consensus claims yet — be the first to contribute
Literature
No studies linked yet — know of one? Share it in the discussion
Discussion
No discussion yet — be the first to share your experience